human
zona
pellucida
virtu
critic
role
fertil
propos
promis
candid
antigen
develop
contracept
vaccin
direct
imper
map
minim
motif
b
cell
epitop
bce
avoid
zpspecif
oophoritogen
cell
epitop
tce
immunogen
studi
base
known
result
map
marmoset
bonnet
monkey
two
predict
epitop
first
confirm
five
minim
motif
within
four
epitop
defin
use
serum
recombin
well
biosynthet
peptid
strategi
defin
minim
motif
qplwll
mqvtdd
eenw
well
snswf
egp
respect
furthermor
antigen
two
peptid
specif
antibodi
respons
peptid
also
evalu
produc
hightit
antibodi
immun
anim
capabl
react
zp
human
oocyt
protein
well
epitop
peptid
fuse
truncat
protein
human
zona
pellucida
hzp
extracellular
matrix
surround
egg
consist
four
sulfat
glycoprotein
design
zp
glycoprotein
mediat
sever
critic
event
fertil
process
initi
recognit
bind
spermatozoa
egg
speciesspecif
manner
induct
acrosom
reaction
zonabound
spermatozoon
prevent
polyspermi
virtu
critic
role
fertil
zp
glycoprotein
propos
target
develop
contracept
vaccin
although
activ
immun
purifi
recombin
zp
rzp
protein
induc
infertil
variou
mammalian
speci
contracept
efficaci
invari
associ
either
transient
alter
complet
loss
ovarian
function
observ
ovarian
patholog
follow
activ
immun
zp
antigen
may
due
presenc
zpspecif
tcell
epitop
tce
within
bcell
epitop
bce
exampl
peptid
correspond
mous
amino
acid
aa
residu
peptid
ii
autoimmun
ovarian
diseas
aod
adopt
transfer
peptideactiv
tcell
recipi
occur
antipeptid
antibodi
administ
iii
minim
modifi
bce
peptid
longer
zpspecif
tce
phenylalanin
key
residu
oophoritogen
tce
substitut
alanin
induc
infertil
mice
eight
differ
haplotyp
without
aod
colinearli
synthes
foreign
promiscu
tce
observ
clearli
suggest
new
possibl
approach
develop
bce
peptidebas
zp
vaccin
fertil
control
devoid
zpspecif
tce
therefor
effort
made
sever
laboratori
delin
infertilityassoci
bce
zp
protein
sinc
bce
first
identifi
dean
et
al
instanc
five
bce
peptid
map
addit
two
epitop
correspond
aa
residu
also
predict
base
map
result
marmoset
bonnet
monkey
macaca
radiata
protein
aa
sequenc
highli
conserv
among
well
protein
elimin
potenti
oophoritisinduc
tce
within
map
longer
bce
peptid
identif
minim
motif
map
bce
hamper
due
limit
avail
map
method
far
minim
motif
bce
cterminu
identifi
use
rabbit
serum
report
previous
identif
minim
motif
epitop
use
improv
peptid
biosynthesi
strategi
first
time
truncat
streptavidin
glutathion
stransferas
use
protein
carrier
respect
addit
sera
made
react
human
oocyt
therefor
main
aim
present
studi
map
minim
motif
four
linear
bce
biosynthet
peptid
antibodi
moreov
immunogen
two
chemic
synthes
peptid
conjug
keyhol
limpet
hemocyanin
klh
also
evalu
rabbit
plasmid
antibodi
peptid
plasmid
use
express
variou
biosynthet
peptid
e
coli
rabbit
sera
prepar
describ
previous
use
bce
identif
minim
motif
map
peptid
fslrlmeenwnaekr
sfskpsnswfpvegp
correspond
well
petqpgpltlelqiakdk
correspond
produc
synthes
sangon
co
shanghai
china
puriti
hplc
peptid
use
antigen
test
antibodi
elisa
peptid
use
unrel
control
peptid
elisa
reagent
chemic
purchas
sangon
co
unless
otherwis
state
express
e
coli
truncat
fusion
protein
describ
earlier
similarli
four
set
overlap
peptid
correspond
sequenc
also
made
overlap
residu
briefli
synthes
anneal
dna
fragment
encod
peptid
correspond
cdna
sequenc
incorpor
bamh
taasal
cohes
end
end
insert
bamh
sal
site
downstream
gene
plasmid
result
recombin
plasmid
express
target
short
peptid
fuse
protein
transform
plyss
e
coli
strain
novagen
inc
madison
wi
usa
recombin
clone
first
grown
ml
luria
broth
lb
contain
ml
ampicillin
c
continu
shake
rpm
overnight
next
day
cell
suspens
inocul
ml
fresh
lb
grown
cell
densiti
reach
grown
h
c
induc
express
recombin
protein
screen
posit
recombin
clone
cell
pellet
harvest
induc
target
clone
first
use
run
sdspage
gel
use
pellet
contain
protein
express
plasmid
neg
control
nucleotid
nt
sequenc
recombin
clone
subsequ
determin
unit
gene
hold
ltd
shanghai
cell
pellet
contain
short
peptid
fusion
protein
store
c
blot
cell
pellet
obtain
ml
cultur
boil
sampl
load
buffer
min
protein
resolv
sdspage
reduc
condit
use
gel
gel
either
stain
coomassi
brilliant
blue
analyz
band
fusion
protein
process
western
blot
electrotransf
protein
onto
nitrocellulos
membran
whatman
gmbh
dossel
germani
complet
transfer
protein
ensur
stain
nitrocellulos
membran
wv
ponceau
nitrocellulos
membran
subsequ
process
western
blot
use
rabbit
antisera
dilut
pb
contain
tween
skim
milk
powder
immun
sera
dilut
specif
antigenantibodi
reaction
membran
visual
use
goat
antirabbit
igg
conjug
horseradish
peroxidas
hrp
proteintech
group
inc
chicago
ill
usa
dilut
blot
develop
use
diaminobenzidin
dab
sigma
mo
usa
mm
pb
contain
h
reaction
stop
wash
membran
extens
mq
water
case
enhanc
chemiluminesc
also
perform
use
ecl
plu
western
blot
detect
reagent
ge
healthcar
buckinghamshir
uk
accord
manufactur
instruct
care
treatment
anim
base
standard
laboratori
anim
care
clinic
development
immunolog
protocol
approv
institut
anim
care
committe
six
male
new
zealand
white
rabbit
obtain
sipprbk
lab
anim
co
ltd
shanghai
china
immun
schedul
follow
six
rabbit
number
weigh
kg
immun
intramuscularli
mg
chemic
synthes
peptid
conjug
klh
sigma
emulsifi
complet
freund
adjuv
cfa
sigma
multipl
site
rabbit
back
respect
anim
boost
three
time
intramuscularli
mg
peptid
antigen
emulsifi
incomplet
freund
adjuv
sigma
week
interv
serum
sampl
immun
anim
collect
day
third
booster
antibodi
titer
assess
elisa
nonimmun
sera
two
anim
number
receiv
cfa
unrel
peptid
antigen
use
neg
control
elisa
respect
elisa
elisa
plate
greiner
bioon
germani
coat
synthet
peptid
ng
per
well
overnight
rt
unbound
synthet
peptid
wash
pb
contain
tween
pbst
sera
dilut
block
buffer
pb
contain
skim
milk
powder
tween
ad
well
twofold
serial
dilut
incub
h
rt
plate
wash
three
time
pbst
visual
specif
peptideantibodi
reaction
goatantirabbit
igg
conjug
hrp
dilut
pb
ad
well
incub
h
rt
well
treat
mg
ml
ophenylenediamin
vv
h
wash
reaction
stop
h
final
absorb
read
nm
accord
manufactur
instruct
thermo
fisher
scientif
pittsburgh
pa
usa
product
number
use
elx
univers
micropl
reader
biotek
instrument
inc
vt
usa
neg
control
amount
unrel
synthet
peptid
use
coat
well
addit
rabbit
preimmun
serum
also
use
neg
control
immunofluoresc
experi
use
human
oocyt
approv
institut
ethic
committe
human
oocyt
fail
fertil
vitro
fertil
ivf
treatment
kindli
donat
sign
written
consent
use
oocyt
obtain
particip
reactiv
antisera
nativ
human
zp
evalu
indirect
immunofluoresc
briefli
oocyt
wash
thrice
pb
contain
mg
ml
polyvinylalcohol
pva
fix
wv
paraformaldehyd
pb
min
rt
next
fix
oocyt
wash
pbspva
incub
min
block
solut
contain
normal
goat
serum
oocyt
incub
dilut
preimmun
immun
sera
pbspva
h
c
wash
pbspva
final
ly
oocyt
treat
dilut
alexa
fluor
goat
antirabbit
igg
invitrogen
calif
usa
min
c
wash
treat
oocyt
pbspva
examin
nikon
invert
microscop
nikon
co
tokyo
japan
determin
whether
identifi
predict
bce
peptid
could
recogn
rabbit
sera
peptid
fuse
truncat
construct
dna
recombin
technolog
shown
figur
fusion
protein
express
e
coli
surprisingli
electrophoret
mobil
short
peptid
fuse
truncat
seem
match
molecular
weight
protein
figur
lane
migrat
similarli
protein
lane
protein
lane
although
aberr
behavior
explain
present
electrophoret
result
reliabl
respect
nt
sequenc
match
aa
sequenc
express
respect
fusion
protein
observ
uninduc
clone
data
shown
six
peptid
could
recogn
antiserum
fail
react
immun
sera
western
blot
figur
b
result
confirm
three
bce
peptid
five
bce
peptid
identifi
previous
three
predict
bce
peptid
also
react
antibodi
word
studi
show
least
five
bce
peptid
protein
select
identifi
minim
motif
sera
except
motif
known
four
set
thirtyseven
peptid
overlap
aa
residu
peptid
construct
use
map
minim
motif
studi
peptid
express
e
coli
higher
level
figur
other
shown
shown
figur
three
bc
two
well
four
six
e
overlap
peptid
fuse
recogn
serum
construct
share
sequenc
aa
aa
well
aa
aa
respect
figur
thu
minim
bind
motif
local
residu
qplwll
mqvtdd
eenwna
snswf
egp
epitop
peptid
two
minim
motif
peptid
identifi
suggest
two
nest
bce
addit
prejudg
peptid
recogn
serum
map
epitop
sequenc
conserv
among
amino
acid
level
howev
gener
blot
brown
band
posit
fusion
protein
initi
use
dab
color
due
rel
lower
sensit
result
shown
therefor
set
peptid
fuse
construct
suit
chemoluminesc
detect
blot
membran
identifi
use
highsensit
ecl
plu
western
blot
detect
reagent
result
peptid
recogn
serum
figur
b
lane
thu
minim
motif
peptid
final
defin
accord
share
sequenc
aa
residu
eenw
minim
motif
map
initi
investig
compar
antigen
peptid
two
rabbit
number
number
immun
synthet
peptid
antigen
fca
conjug
klh
shown
figur
peptid
antigen
elicit
higher
antibodi
respons
peptid
immun
anim
rabbit
number
immun
antigen
show
antibodi
titer
wherea
level
rabbit
number
immun
antigen
reach
approxim
elisa
assay
figur
serum
react
carrier
protein
lane
serum
data
shown
suggest
crossreact
antibodi
protein
immun
sera
addit
serum
react
peptid
contain
map
minim
motif
snfwf
egp
figur
b
lane
confirm
map
result
two
overlap
bce
within
epitop
peptid
figur
e
figur
b
shown
figur
rabbit
serum
dilut
show
strong
posit
reaction
human
zp
ij
red
fluoresc
absent
oocyt
treat
preimmun
serum
gh
result
show
product
specif
immunoglobulin
reactiv
epitop
peptid
human
zp
elicit
peptid
immun
rabbit
respect
protein
interest
target
antigen
develop
contracept
peptid
vaccin
two
bce
first
identifi
serum
synthet
peptid
base
comput
predict
sequenc
comparison
known
bce
sequenc
protein
mani
mammal
former
mer
peptid
howev
recogn
sera
elisa
serum
western
blot
figur
b
lane
suggest
might
selfepitop
peptid
although
could
elicit
antibodi
capabl
bind
nativ
hzp
antiserum
might
use
marker
identif
protein
latter
mer
peptid
elicit
antibodi
react
human
zp
transgen
mice
although
fail
identifi
serum
studi
epitop
map
result
peptid
could
recogn
serum
studi
figur
b
lane
suggest
epitop
well
mer
peptid
map
serum
could
react
serum
studi
figur
b
lane
present
explain
distinct
map
result
includ
abovement
peptid
group
employ
differ
antisera
resp
antigen
immunogen
previous
report
synthet
peptid
elicit
antibodi
capabl
react
nativ
mstzp
bmzp
hzp
respect
peptid
sequenc
highli
conserv
sequenc
mstserum
link
promiscu
helper
tce
tetanu
toxoid
show
inhibit
human
spermzona
bind
vitro
convers
bmserum
conjug
diphtheria
toxoid
fail
show
signific
decreas
spermzona
bind
hemizona
assay
reason
discord
clear
research
requir
explain
find
present
studi
differ
one
residu
posit
p
antigen
specif
preliminarili
evalu
use
synthet
peptid
conjug
klh
compar
peptid
shown
figur
peptid
elicit
hightit
antibodi
react
nativ
hzp
peptid
express
e
coli
antigen
latter
significantli
greater
former
antigen
divers
peptid
one
possibl
explan
might
antibodi
two
overlap
bce
nsnwf
egp
within
peptid
sequenc
efficaci
antiserum
inhibit
human
spermzona
bind
remain
evalu
carri
competit
hemizona
spermegg
bind
assay
serum
synthet
peptid
often
use
map
minim
motif
identifi
bce
peptid
check
specif
peptid
antigen
western
blot
carri
two
set
mer
peptid
surprisingli
rabbit
serum
could
recogn
peptid
also
react
peptid
recogn
rabbit
serum
wherea
serum
recogn
peptid
recogn
peptid
react
serum
data
shown
data
suggest
bce
motif
gener
drift
phenomenon
use
serum
synthet
peptid
map
minim
motif
compar
result
identifi
serum
minim
motif
map
serum
synthet
peptid
nativ
rprotein
might
differ
sometim
synthet
peptid
method
often
use
delin
linear
bce
protein
howev
number
map
bce
alway
less
bce
miss
use
serum
rprotein
elisa
instanc
follow
hold
bce
includ
bce
cterminu
transmembranelik
domain
map
serum
choexpress
compar
result
map
bce
studi
could
defin
mani
bce
six
potenti
reactiv
neighbor
epitop
map
brushtail
possum
bp
sera
might
one
caus
sever
bce
peptid
could
miss
could
defin
two
epitop
map
studi
use
synthet
peptid
librari
know
may
one
bce
map
two
neighbor
overlap
peptid
share
common
sequenc
may
also
two
three
bce
accord
epitop
map
result
protein
hpv
type
viru
data
shown
obvious
drawback
employ
method
map
bce
protein
could
use
carri
minim
motif
identif
reactiv
neighbor
peptid
serum
rprotein
way
answer
mani
bce
studi
express
singl
bce
peptid
fuse
core
protein
epitop
map
sever
purifi
short
peptid
fuse
suggest
possibl
use
biosynthet
peptid
map
linear
bce
minim
motif
protein
howev
like
studi
use
mab
chicken
sera
sarscov
sar
convalesc
sera
need
solv
key
problem
employ
serum
rprotein
avoid
interf
antibodi
strong
antigen
e
coli
distinguish
target
blot
band
rprotein
use
immunogen
alway
contain
littl
bacteria
protein
could
complet
remov
purifi
laboratori
level
present
problem
solv
use
truncat
carrier
short
peptid
express
show
figur
blot
band
peptid
locat
weak
antigen
area
bacteri
protein
blot
membran
avoid
two
blot
band
bacteri
protein
kda
kda
band
obvious
besid
simpl
cheap
reliabl
adapt
merit
mention
previou
work
present
studi
show
anoth
two
distinct
advantag
improv
biosynthet
peptid
strategi
permit
use
serum
bacteriaexpress
protein
map
bce
minim
motif
cf
match
light
imag
human
oocyt
imag
immunofluoresc
panel
gj
gj
reactiv
rabbit
sera
human
oocyt
indirect
immunofluoresc
repres
immunofluoresc
pattern
shown
g
preimmun
serum
h
immun
serum
receiv
cfa
ij
immun
serum
target
protein
peptid
fusion
protein
express
plasmid
could
use
western
blot
without
purifi
addit
smallest
bind
motif
residu
antibodi
defin
biosynthet
peptid
figur
e
figur
wherea
length
map
synthet
peptid
method
residu
summari
studi
first
util
biosynthet
peptid
sera
andor
map
bce
minim
motif
protein
identif
five
minim
motif
within
four
epitop
help
develop
contracept
vaccin
multiepitop
zp
peptid
without
zpspecif
tce
activ
may
result
ovarian
dysfunct
human
use
futur
defin
bce
minim
motif
would
also
use
specif
probe
detect
whether
selfzp
antibodi
bce
sera
patient
infertil
andor
prematur
ovarian
failur
furthermor
data
present
clearli
suggest
biosynthet
peptid
strategi
employ
studi
could
use
map
bce
precis
linear
epitop
entir
zp
protein
speci
